1279031-09-2 Usage
Uses
Used in Pharmaceutical Industry:
GALANTHAMINE-O-METHYL-D3 is used as a therapeutic agent for the treatment of Alzheimer's disease. It functions as a selective acetylcholinesterase inhibitor, which helps in increasing the levels of acetylcholine, a neurotransmitter that plays a crucial role in memory and cognitive functions. By inhibiting the enzyme acetylcholinesterase, GALANTHAMINE-O-METHYL-D3 can slow down the progression of cognitive decline associated with Alzheimer's disease.
Additionally, due to its deuterated nature, GALANTHAMINE-O-METHYL-D3 may exhibit improved pharmacokinetic properties, such as enhanced stability and bioavailability, compared to its non-deuterated counterparts. This can potentially lead to better therapeutic outcomes and reduced side effects for patients undergoing treatment for Alzheimer's disease.
Check Digit Verification of cas no
The CAS Registry Mumber 1279031-09-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,9,0,3 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1279031-09:
(9*1)+(8*2)+(7*7)+(6*9)+(5*0)+(4*3)+(3*1)+(2*0)+(1*9)=152
152 % 10 = 2
So 1279031-09-2 is a valid CAS Registry Number.
1279031-09-2Relevant articles and documents
Synthesis of deuterium-labelled (-)-galanthamine
Rouleau, Julien,Guillou, Catherine
, p. 236 - 238 (2008/12/20)
The synthesis of deuterium-labelled galanthamine is reported. 6-[ 2H3]methoxy-N-[2H3]methyl-(-)- galanthamine was obtained in seven steps from galanthamine. The synthesis was carried out by selective O- and N-de
